Aakha Biologics
PrivateLast Round
Debt
Jul 23, 2024
Total Funding Raised
$3.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aakha Biologics is a biotechnology company that develops next-generation multi-specific antibody immunotherapies for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aakha Biologics Comparables
Compare Aakha Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ypsilon Therapeutics | 83% | |
| Cantai Therapeutics | 82% | |
| Cullinan Oncology | 76% | |
Aakha Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 23, 2024 | ||||
| Seed | Jul 17, 2024 | ||||
| Grant | May 22, 2024 | ||||
| Accelerator | May 1, 2021 |
Key People
Founding team and executive leadership
Aakha Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Opus8 | Seed |
| 82VS | Accelerator |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
Grew 60% QoQ from 5 to 8 employees.
- May 1, 2021
Raised an accelerator round with 82VS and Alloy Therapeutics.
Aakha Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aakha Biologics's valuation, stock price, and market status.